Clinical Trial Update: Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT) [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating an engineered donor graft named Orca Q for pediatric hematopoietic cell transplantation is currently suspended. The sponsor listed i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia in Accelerated Phase
• Chronic Myeloid Leukemia in Lymphoid Blast Crisis
• Chronic Myeloid Leukemia in Myeloid Blast Crisis
• Mixed Phenotype Acute Leukemia
• Undifferentiated Leukemia

Drugs mentioned

• Orca Q Engineered Donor Graft

Snippet

Sponsor: University of Florida | Conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia | Phase 1, Phase 2 | Status: SUSPENDED